Browsing Tag
Oncology Devices
2 posts
How the Japan patent allowance could strengthen RenovoRx’s oncology platform valuation story
Could RenovoRx’s Japan patent strengthen the RNXT valuation story? Read what this means for growth, competition, and investor sentiment.
Aethlon Medical, Inc. (NASDAQ: AEMD) flags accelerating clinical enrollment as Hemopurifier strategy tightens
Find out how Aethlon Medical’s faster clinical enrollment reshapes execution risk, investor sentiment, and the future of the Hemopurifier platform.